000			03709nam a2200349 i 4500
999			_c398905 _d398905
001			398905
003			ES-MaUEC
005			20240320164027.0
006			a|||| o|||| 00| 0
007			cr nn 008mamaa
008			230131s2023 sz | o |||| 0|eng d
020			_a9783031073922
024	7		_a10.1007/978-3-031-07392-2 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRA1211 _b2023 EB
245	0	0	_aBiomarkers in Toxicology _cedited by Vinood B. Patel, Victor R. Preedy, Rajkumar Rajendram
250			_a1st ed. 2023
264		1	_aCham _bSpringer International Publishing _c2023
300			_a1 recurso en línea
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	0		_aBiomarkers in Disease: Methods, Discoveries and Applications _x2542-3665
505	0		_aMarkers of liver toxicity and biomarkers -- Biomarkers of kidney toxicity. -Biomarkers of cardiac toxicity: microRNA and beyond.-Biomarkers of gastrointestinal toxicity -- Biomarkers of skin toxicity -- Skeletal muscle biomarkers in toxicity studies -- Bone markers of toxicity -- biochemical markers of brain damage -- DNA adducts as biomarkers of nutritional toxicity -- Biomarkers of pollution toxicity: measuring heavy metals in blood -- Challenge-comet assay: applications to toxicity -- Alkylation adducts of nucleic acids as a biomarkers .-TGx-DDI transcriptomic biomarker: Features and applications.-DNA biomarkers: an updated narrative -- CRISPR/Cas9 Whole-Genome Screens: applications to environmental pollutants.-Apoptotic biomarkers in toxicity studies -- 5'UTR methylation as a biomarkers: investigating volatile organics -- 5-Fluorouracil degradation rate and a biomarker of capecitabine toxicity -- Investigating the blood-brain barrier as a marker of toxicology -- Biomarkers of oxidative stress: investigating apigenin -- Histology as a biomarker in toxicity: applications to investigating Syzygium guineense -- Hair metabolomics and biomarker discovery .-Markers of hepatotoxicity using metabolomics: applications to MDMA, ecstasy -- 1H-NMR metabolomics and biomarkers of myotoxins -- Nanoparticle-induced toxicity and transcriptomics as a biomarker discovery platform -- Urine metabolomics and biomarker discovery.-microRNA profiling as a biomarker platform: carcinogens and beyond.
520			_aThis handbook of the series Biomarkers in Disease informs comprehensively about all aspects of monitoring and detecting toxicity in the human body and model organisms. Biomarkers for assessing toxicity in diverse organs are presented and different assays and methods are explained. Single compounds and drugs and their toxicity for humans are shown and the methods for detection described. Similar to all the volumes of the Biomarkers in Disease series, the chapters are written by experts in their field, each chapter features key facts summarizing the most important aspects of its respective topic and the definitions of words and terms facilitate the reading and understanding. This handbook is a must-have for researchers in toxicology and biomedicine who analyze the effects of drugs and various other substances in the human body and in model organisms. It also serves as a thorough guide for clinicians and pharmacologists.
988			_aSpringer_BiomedLife_2023
650		7	_2embne _9140328 _aToxicología
650		7	_2embne _9162047 _aMarcadores biológicos
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-07392-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b03/2024 _dz _eb _zSI